Dihydrofolate reductase
|
|
Missing image
DihydrofolateReductase-7DFR.png
DihydrofolateReductase-7DFR.png
Dihydrofolate reductase
Dihydrofolate reductase (PDB 7DFR (http://www.rcsb.org/pdb/cgi/explore.cgi?pid=117351033147076&pdbId=7DFR), EC 1.5.1.3 (http://www.expasy.org/cgi-bin/nicezyme.pl?1.5.1.3)), or DHFR, reduces dihydrofolic acid to tetrahydrofolic acid, which can be converted to the kinds of tetrahydrofolate cofactors used in 1-carbon transfer chemistry.
A variety of drugs act on dihydrofolate reductase, including the antibiotic trimethoprim, the antimalarial drug pyrimethamine, and the chemotherapeutic agents methotrexate and pemetrexed. The first anticancer drug, aminopterin, also acts on this enzyme, binding some 1000 times more tightly to the enzyme than folate itself.
External links
- 1988 Nobel lecture in Medicine (http://www.nobel.se/medicine/laureates/1988/hitchings-lecture.pdf)